More Jiangsu Nhwa Pharmaceutical Co., Ltd. news
Jiangsu Nhwa Pharmaceutical Co., Ltd.SZSE: 002262

Jiangsu Nhwa Pharmaceutical Says 2025 Net Profit Down 7.5%

Apr 17, 2026 at 7:22 AM EDT · Issued by Jiangsu Nhwa Pharmaceutical Co., Ltd.

On 6ix: 6ix.com/news/jiangsu-nhwa-pharmaceutical-says-2025-net-profit-down-7.5percent

Jiangsu Nhwa Pharmaceutical Co Ltd SZSE:002262:

  • SAYS 2025 NET PROFIT DOWN 7.5% Y/Y

Jiangsu Nhwa Pharmaceutical Co., Ltd. on 6ix

Earlier from Jiangsu Nhwa Pharmaceutical

  • Jiangsu Nhwa Pharmaceutical: Q3 2025 revenue and net profit rose 5.70% and 3.67% year-over-year, respectivelyOct 25, 2025
  • Jiangsu Nhwa Pharmaceutical Q3 Net Profit Up 3.7% Y/YOct 24, 2025
  • Jiangsu Nhwa Pharmaceutical: Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growthJul 29, 2025
  • Jiangsu Nhwa Pharmaceutical: Q1 2025 net profit up 13.35% year-over-year on strong sales and investment returnsApr 19, 2025
  • Jiangsu Nhwa Pharmaceutical: 2024 revenue and net profit rose double digits, with strong CNS drug and digital health growthMar 29, 2025

Later from Jiangsu Nhwa Pharmaceutical

  • Jiangsu Nhwa Pharmaceutical: Revenue up 3.75%, net profit down 7.54%, strong R&D and cash flow, dividend proposedApr 17
All Jiangsu Nhwa Pharmaceutical news releases↗

Follow Jiangsu Nhwa Pharmaceutical into a list and get an email when it puts out news.

Follow Jiangsu Nhwa Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer